Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stephen Yip

Showing results (61-70 of 212) with videos related to

Pageof 22
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 9, 2009
MSH6 mutations arise in glioblastomas during temozolomide therapy and mediate temozolomide resistanceStephen Yip, Jiangyong Miao, Daniel P Cahill, et al.
Neuro-Oncology|February 9, 2022
The impact of brain invasion criteria on the incidence and distribution of WHO grade 1, 2, and 3 meningiomasAlexander D Rebchuk, Bradley M Chaharyn, Armaghan Alam, et al.
Current Oncology (Toronto, Ont.)|January 20, 2023
Disparate Time-to-Treatment and Varied Incidence of Actionable Non-Small Cell Lung Cancer Molecular Alterations in British Columbia: A Historical Cohort StudyRoy Avraham Hilzenrat, Stephen Yip, Barbara Melosky, et al.
BMC Biology|October 29, 2020
TRIM25 promotes Capicua degradation independently of ERK in the absence of ATXN1LDerek Wong, Lisa Sogerer, Samantha S Lee, et al.
Therapeutics and Clinical Risk Management|June 23, 2015
Novel targeted therapies in chordoma: an updateSalvatore Di Maio, Stephen Yip, Gmaan A Al Zhrani, et al.
The Journal of Pathology|March 16, 2017
Comparative transcriptome analysis of isogenic cell line models and primary cancers links capicua (CIC) loss to activation of the MAPK signalling cascadeVeronique G LeBlanc, Marlo Firme, Jungeun Song, et al.
BMJ Open Quality|February 19, 2025
Reduced wait times for molecular-biomarker testing among patients with advanced lung cancer using parallel sample processing and closed-loop communication: the Continuous Oncopanel and ALK Status Tracking (COAST) ProjectSarah Yeo, Jane Sun, Kelly Zibrik, et al.
Otology & Neurotology : Official Publication of the American Otological Society, American Neurotology Society [And] European Academy of Otology and Neurotology|June 12, 2026
Tumor-to-Tumor Metastasis Involving Vestibular Schwannoma: Case Report and Literature ReviewPatrick R Toyota, Celine D Hounjet, Eva Liu, et al.
Lung Cancer Management|April 30, 2020
Optimizing molecular residual disease detection using liquid biopsy postoperatively in early stage lung cancerAnna L McGuire, Curtis B Hughesman, Melissa K McConechy, et al.
Neuro-Oncology Advances|January 30, 2024
Molecular prognostication in grade 3 meningiomas and p16/MTAP immunohistochemistry for predicting <i>CDKN2A/B</i> statusKira Tosefsky, Karina Chornenka Martin, Alexander D Rebchuk, et al.
Pageof 22

Showing results (61-70 of 212) with videos related to

Sort By:
Pageof 22
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 9, 2009
MSH6 mutations arise in glioblastomas during temozolomide therapy and mediate temozolomide resistanceStephen Yip, Jiangyong Miao, Daniel P Cahill, et al.
Neuro-Oncology|February 9, 2022
The impact of brain invasion criteria on the incidence and distribution of WHO grade 1, 2, and 3 meningiomasAlexander D Rebchuk, Bradley M Chaharyn, Armaghan Alam, et al.
Current Oncology (Toronto, Ont.)|January 20, 2023
Disparate Time-to-Treatment and Varied Incidence of Actionable Non-Small Cell Lung Cancer Molecular Alterations in British Columbia: A Historical Cohort StudyRoy Avraham Hilzenrat, Stephen Yip, Barbara Melosky, et al.
BMC Biology|October 29, 2020
TRIM25 promotes Capicua degradation independently of ERK in the absence of ATXN1LDerek Wong, Lisa Sogerer, Samantha S Lee, et al.
Therapeutics and Clinical Risk Management|June 23, 2015
Novel targeted therapies in chordoma: an updateSalvatore Di Maio, Stephen Yip, Gmaan A Al Zhrani, et al.
The Journal of Pathology|March 16, 2017
Comparative transcriptome analysis of isogenic cell line models and primary cancers links capicua (CIC) loss to activation of the MAPK signalling cascadeVeronique G LeBlanc, Marlo Firme, Jungeun Song, et al.
BMJ Open Quality|February 19, 2025
Reduced wait times for molecular-biomarker testing among patients with advanced lung cancer using parallel sample processing and closed-loop communication: the Continuous Oncopanel and ALK Status Tracking (COAST) ProjectSarah Yeo, Jane Sun, Kelly Zibrik, et al.
Otology & Neurotology : Official Publication of the American Otological Society, American Neurotology Society [And] European Academy of Otology and Neurotology|June 12, 2026
Tumor-to-Tumor Metastasis Involving Vestibular Schwannoma: Case Report and Literature ReviewPatrick R Toyota, Celine D Hounjet, Eva Liu, et al.
Lung Cancer Management|April 30, 2020
Optimizing molecular residual disease detection using liquid biopsy postoperatively in early stage lung cancerAnna L McGuire, Curtis B Hughesman, Melissa K McConechy, et al.
Neuro-Oncology Advances|January 30, 2024
Molecular prognostication in grade 3 meningiomas and p16/MTAP immunohistochemistry for predicting <i>CDKN2A/B</i> statusKira Tosefsky, Karina Chornenka Martin, Alexander D Rebchuk, et al.
Pageof 22